🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical research study is to learn if the combination of ...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2003-09
Trial ID
NCT00504660
Treatments Being Tested
This phase II/III trial compares the effect of the combination treatment wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-30
Trial ID
NCT05432791
The purpose of this study is to determine whether nilotinib is efficacious ...
Status
Completed
Location
City of Hope National Medical Center City of Hope national Med Ctr
Start Date
2010-06
Trial ID
NCT01028222
The aim of CABOTEM study is to demonstrate the safety and activity of the C...
Status
Recruiting
Location
National Cancer Institute of Naples
Start Date
2021-06-15
Trial ID
NCT04893785
Treatments Being Tested
The early clinical development paradigm for chemotherapeutic agents has sig...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2015-12-03
Trial ID
NCT02510950
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Universitair Medisch Centrum St. Radboud - Nijmegen
Start Date
2006-10
Trial ID
NCT00433433
Treatments Being Tested
The standard chemotherapy for Hodgkin lymphoma is called ABVD which is a co...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2012-04
Trial ID
NCT01578967
Treatments Being Tested
This is an open-label, two-part, phase 1-2 dose-finding study designed to d...
Status
Active Not Recruiting
Location
University of California, San Francisco
Start Date
2020-07-01
Trial ID
NCT04478279
Treatments Being Tested
The primary objective of this trial is to investigate whether the addition ...
Status
Recruiting
Location
Institut Bergonie
Start Date
2019-02-14
Trial ID
NCT03805022
The purpose of this study is to evaluate the safety of vismodegib in combin...
Status
Terminated
Location
CHU La Timone
Start Date
2012-06
Trial ID
NCT01601184
Treatments Being Tested